Connect with me
I'm part of

About me

Professor Geoffrey Guy (MB BS, LRCP MRCS, LMSSA, BSc, Dip Pharm Med) holds a BSc. in pharmacology from the University of London, an MBBS at St. Bartholomew’s Hospital, an MRCS Eng. and LRCP London, an LMSSA Society of Apothecaries and a Diploma of Pharmaceutical Medicine from the Royal Colleges of Physicians.Prof Guy was appointed Visiting Professor in the Department of Life Science at the University of Westminster in 2015 and works in collaboration with the Research Centre for Optimal Health

Prof Guy is the founder of GW Pharmaceuticals and has served as Chairman since 1998.  Dr Guy has over 30 years of experience in medical research and global drug development, most recently as Chairman and Chief Executive of Ethical Holdings plc, a Nasdaq-quoted drug delivery company (now Amarin Corporation plc, or Amarin), which he founded in 1985 and led to its Nasdaq listing in 1993.

In 1996 Prof Guy was awarded the Entrepreneur of the Year in the Technology Section of the 3i annual awards.   He was also the recipient of the “Deloitte Director of the Year Award in Pharmaceuticals and Healthcare” in 2011.


The overall aim underlying my future research is to use quantum biology to drive the next revolution in medicine

Central to my past and current work has been the development and commercialization of herb-derived medicines, including cannabinoids. I have worked closely with leading scientific institutions in determining the mode-of-action of some of these natural compounds and their effects on health and disease. 

More recently my focus has turned to understanding the role of quantum effects in biological processes. It seems that the emergence of life may have been dependent on “stressing” or “perturbing” a set of molecules in an energy gradient, so enabling order out of chaos by entraining information, while accelerating entropy in a kind of dissipative structure that became subject to natural selection. Critically, it seems that “life” has in this process also embraced fundamental quantum effects in order to work, and possibly, even detect the environment, which might suggest that localised coherence is key in detecting perturbations. My current work at the University of Westminster aims at unravelling the extent to which may biological process in health and disease are dictated by quantum physics and how we can utilise these to maximise health.